NAPSRX STUDY GUIDE
SET WITH COMPLETE
SOLUTIONS
PharmaceuticalsW-WcorrectWanswer-
MedicinesWandWvaccinesWforWhumanWandWanimalWuse.WProductsWmayWhaveWaWtr
ademarkW(brand)WnameWorWbeWgeneric;WandWtheyWmayWbeWprescriptionWorWover
-theWcounter.
DiagnosticW-WcorrectWanswer-
EquipmentWandWsuppliesWusedWinWscreening,Wdetecting,WandWmonitoringWdisease
.WCanWrangeWfromWsimpleWhomeWtestingWkitsWtoWsophisticatedWdiagnosticWimagin
gWtechnologies.
MedicalWDevicesW-WcorrectWanswer-
AdvancedWinstrumentationWandWappliancesWusedWforWmedicalWtherapy,WsuchWasW
jointWreplacements,WimplantableWdefibrillators,WandWpacemakers.WAlsoWincludesWd
rugWdeliveryWdevicesWsuchWasWsyringes,WinfusionWpumps,Wmetered-
doseWinhalers,WandWtransdermalWpatches.
MedicalWSuppliesW-WcorrectWanswer-Commodity,Whigh-
volumeWsuppliesWsuchWasWsurgicalWgownsWandWgloves.
DurableWMedicalWEquipmentW-WcorrectWanswer-ReusableWproductsWforWhealth-
relatedWuseWinWtheWhome,WsuchWasWwalkers,Wwheelchairs,WoxygenWequipment,W
prostheticsWandWhospitalWbeds.
,WhatWcountriesWareWpharmaceuticalWsalesWtheWhighest?W-WcorrectWanswer-
UnitedWStates,WWesternWEurope,WandWJapan.
TheWU.S.WaccountsWforWroughlyW__________WofWtheWworld'sWpharmaceuticalWrev
enues.W-WcorrectWanswer-50%
TwoWfactorsWhaveWsignificantlyWcontributedWtoWrecentWgrowthWinWtheWpharmaceut
icalWindustryWare?W-WcorrectWanswer-
PopulationWgrowthWandWincreasingWlifeWexpectancies.
WhatWisWtheWpredictedWrelationshipWbetweenWpharmaceuticalWcompaniesWandWge
nomicWresearchWfacilities?W-WcorrectWanswer-
PartnershipsWbetweenWpharmaceuticalWcompaniesWandWgenomicWresearchWfaciliti
esWwillWnotWproveWimmediatelyWprofitable.
PrescriptionWdrugWtherapyWisWcostWeffectiveWforWinsuranceWcompaniesWandWhealt
hWcareWproviders.WTrueWorWFalse?W-WcorrectWanswer-True
TheWhighWpriceWofWhealthWcareWisWexplainedWbyWtheWhighWpriceWofWmedicines.W
TrueWorWFalse?W-WcorrectWanswer-False
OneWofWtheWoldestWandWleastWeffectiveWpharmaceuticalWmarketingWtechniquesWis
WDTCW(direct-to-consumer)Wadvertising.WTrueWorWFalse?W-WcorrectWanswer-False
WhatWinfluencesWtheWnumberWofWdistrictsWinWaWregion?W-WcorrectWanswer-
TheWregion'sWpopulation.
WhatWisWanWexampleWofWtheWregionalizationWofWhealthcareWdeliveryWsystems?W-
WcorrectWanswer-
CaliforniaWandWFloridaWhaveWdifferentWprescriptionWreimbursementWpolicies.
WhatWisWtheWheartWofWaWpharmaceuticalWsalesWteam?W-WcorrectWanswer-
DistrictWManager.
HowWmanyWterritoriesWareWinWaWtypicalWdistrict?W-WcorrectWanswer-8-12
WhatWisWtheWmostWeffectiveWmethodWforWgrabbingWmarketWshare?W-
WcorrectWanswer-ComparativeWselling.
TheWaverageWreviewWtimeWforWaWnewWdrugWisW18Wmonths,WdownWfromWalmostW
3WyearsWinW1996.WTrueWorWFalse?W-WcorrectWanswer-True
WhatWareWsomeWquestionsWrepsWshouldWaskWaWphysician?W-WcorrectWanswer-
WhyWdoWyouWpreferWtheWcompetitor'sWdrugWtoWours?
WWhatWdoWtheyWlikeWandWdislikeWaboutWit?
WWhichWpatientWtypesWisWtheWdrugWbeingWusedWfor?
WWhatWareWtheWresultsWandWsideWeffects,WifWany?W
, Note:WCarefulWquestioningWandWlisteningWenablesWrepsWtoWcraftWeffectiveWmessa
gesWbasedWonWeachWphysician'sWspecificWneeds.
PharmaceuticalWrepsWmainlyWvisitWpharmacies.WTrueWorWFalse?W-
WcorrectWanswer-False.WPharmaceuticalWrepsWmainlyWvisit/targetWphysicians.
ItWusuallyWtakesWonlyW1-
2WcallsWonWaWphysicianWbeforeWheWorWsheWprescribesWyourWproduct.WTrueWorWF
alse?W-WcorrectWanswer-
False.WYourWsuccessWultimatelyWdependsWonWyourWrelationshipWwithWtheWphysici
an.WThisWtakesWtime.WPersistenceWisWkey.
TheWpharmacistWmayWdispenseWaWproductWotherWthanWwhatWtheWphysicianWpres
cribed.WTrueWorWFalse?W-WcorrectWanswer-
True.WTheWpharmacistWcanWeitherW(1)WdispenseWaWgeneric;W(2)WTheWpharmacist
WcallsWtheWdoctorWandWrequestsWpermissionWtoWdispenseWaWdifferentWmedication.
AccordingWtoWchapterW2WofWyourWmanualWwhichWofWtheWfollowingWclassifiesWasW
payers?W
(a)Wemployers
(b)WpatientsW
(c)Wpharmacists
(d)WphysiciansW-WcorrectWanswer-(a)WemployersW
SomeWthirdWpartyWpayersWincludeWtheWinsuranceWcompany,WtheWemployer,Wmana
gedWcareWorganization,WorWtheWU.S.WgovernmentW(Medicare/Medicaid).
WhatWdefinesWethicalWpharmaceuticalWcompanies?W-WcorrectWanswer-
PharmaceuticalWcompaniesWthatWresearchWandWdevelopWnovelWdrugs.
ThanksWtoWmodernWmedicineWhowWlongWareWpeopleWnewlyWdiagnosedWwithWHIV
WexpectedWtoWlive?W-WcorrectWanswer-AnotherW50Wyears.
HowWmuchWhasWtheWaverageWAmericanWlifespanWincreasedWsinceW1890?W-
WcorrectWanswer-30Wyears
WhatWisWaWtreatmentWgroup?W-WcorrectWanswer-
AWgroupWofWpatientsWassignedWtoWreceiveWspecificWtreatment.
WhatWisWtheWmainWdifferenceWbetweenWaWblindedWandWdouble-blindedWstudy?W-
WcorrectWanswer-
InWaWdoubleWblindedWstudy,WneitherWtheWstaffWnorWtheWstudyWparticipantsWknowW
whichWsubjectsWareWinWtheWexperimentalWgroupWandWwhichWsubjectsWareWinWthe
WcontrolWgroup.
WhatWdoesWasymptomaticWmean?W-WcorrectWanswer-
WithoutWsignsWorWsymptomsWofWdisease.
WhatWisWanWapprovableWletter?W-WcorrectWanswer-
LettersWsentWbyWtheWFDAWtoWtheWapplicantWindicatingWwhetherWtheWnewWdrugWa
SET WITH COMPLETE
SOLUTIONS
PharmaceuticalsW-WcorrectWanswer-
MedicinesWandWvaccinesWforWhumanWandWanimalWuse.WProductsWmayWhaveWaWtr
ademarkW(brand)WnameWorWbeWgeneric;WandWtheyWmayWbeWprescriptionWorWover
-theWcounter.
DiagnosticW-WcorrectWanswer-
EquipmentWandWsuppliesWusedWinWscreening,Wdetecting,WandWmonitoringWdisease
.WCanWrangeWfromWsimpleWhomeWtestingWkitsWtoWsophisticatedWdiagnosticWimagin
gWtechnologies.
MedicalWDevicesW-WcorrectWanswer-
AdvancedWinstrumentationWandWappliancesWusedWforWmedicalWtherapy,WsuchWasW
jointWreplacements,WimplantableWdefibrillators,WandWpacemakers.WAlsoWincludesWd
rugWdeliveryWdevicesWsuchWasWsyringes,WinfusionWpumps,Wmetered-
doseWinhalers,WandWtransdermalWpatches.
MedicalWSuppliesW-WcorrectWanswer-Commodity,Whigh-
volumeWsuppliesWsuchWasWsurgicalWgownsWandWgloves.
DurableWMedicalWEquipmentW-WcorrectWanswer-ReusableWproductsWforWhealth-
relatedWuseWinWtheWhome,WsuchWasWwalkers,Wwheelchairs,WoxygenWequipment,W
prostheticsWandWhospitalWbeds.
,WhatWcountriesWareWpharmaceuticalWsalesWtheWhighest?W-WcorrectWanswer-
UnitedWStates,WWesternWEurope,WandWJapan.
TheWU.S.WaccountsWforWroughlyW__________WofWtheWworld'sWpharmaceuticalWrev
enues.W-WcorrectWanswer-50%
TwoWfactorsWhaveWsignificantlyWcontributedWtoWrecentWgrowthWinWtheWpharmaceut
icalWindustryWare?W-WcorrectWanswer-
PopulationWgrowthWandWincreasingWlifeWexpectancies.
WhatWisWtheWpredictedWrelationshipWbetweenWpharmaceuticalWcompaniesWandWge
nomicWresearchWfacilities?W-WcorrectWanswer-
PartnershipsWbetweenWpharmaceuticalWcompaniesWandWgenomicWresearchWfaciliti
esWwillWnotWproveWimmediatelyWprofitable.
PrescriptionWdrugWtherapyWisWcostWeffectiveWforWinsuranceWcompaniesWandWhealt
hWcareWproviders.WTrueWorWFalse?W-WcorrectWanswer-True
TheWhighWpriceWofWhealthWcareWisWexplainedWbyWtheWhighWpriceWofWmedicines.W
TrueWorWFalse?W-WcorrectWanswer-False
OneWofWtheWoldestWandWleastWeffectiveWpharmaceuticalWmarketingWtechniquesWis
WDTCW(direct-to-consumer)Wadvertising.WTrueWorWFalse?W-WcorrectWanswer-False
WhatWinfluencesWtheWnumberWofWdistrictsWinWaWregion?W-WcorrectWanswer-
TheWregion'sWpopulation.
WhatWisWanWexampleWofWtheWregionalizationWofWhealthcareWdeliveryWsystems?W-
WcorrectWanswer-
CaliforniaWandWFloridaWhaveWdifferentWprescriptionWreimbursementWpolicies.
WhatWisWtheWheartWofWaWpharmaceuticalWsalesWteam?W-WcorrectWanswer-
DistrictWManager.
HowWmanyWterritoriesWareWinWaWtypicalWdistrict?W-WcorrectWanswer-8-12
WhatWisWtheWmostWeffectiveWmethodWforWgrabbingWmarketWshare?W-
WcorrectWanswer-ComparativeWselling.
TheWaverageWreviewWtimeWforWaWnewWdrugWisW18Wmonths,WdownWfromWalmostW
3WyearsWinW1996.WTrueWorWFalse?W-WcorrectWanswer-True
WhatWareWsomeWquestionsWrepsWshouldWaskWaWphysician?W-WcorrectWanswer-
WhyWdoWyouWpreferWtheWcompetitor'sWdrugWtoWours?
WWhatWdoWtheyWlikeWandWdislikeWaboutWit?
WWhichWpatientWtypesWisWtheWdrugWbeingWusedWfor?
WWhatWareWtheWresultsWandWsideWeffects,WifWany?W
, Note:WCarefulWquestioningWandWlisteningWenablesWrepsWtoWcraftWeffectiveWmessa
gesWbasedWonWeachWphysician'sWspecificWneeds.
PharmaceuticalWrepsWmainlyWvisitWpharmacies.WTrueWorWFalse?W-
WcorrectWanswer-False.WPharmaceuticalWrepsWmainlyWvisit/targetWphysicians.
ItWusuallyWtakesWonlyW1-
2WcallsWonWaWphysicianWbeforeWheWorWsheWprescribesWyourWproduct.WTrueWorWF
alse?W-WcorrectWanswer-
False.WYourWsuccessWultimatelyWdependsWonWyourWrelationshipWwithWtheWphysici
an.WThisWtakesWtime.WPersistenceWisWkey.
TheWpharmacistWmayWdispenseWaWproductWotherWthanWwhatWtheWphysicianWpres
cribed.WTrueWorWFalse?W-WcorrectWanswer-
True.WTheWpharmacistWcanWeitherW(1)WdispenseWaWgeneric;W(2)WTheWpharmacist
WcallsWtheWdoctorWandWrequestsWpermissionWtoWdispenseWaWdifferentWmedication.
AccordingWtoWchapterW2WofWyourWmanualWwhichWofWtheWfollowingWclassifiesWasW
payers?W
(a)Wemployers
(b)WpatientsW
(c)Wpharmacists
(d)WphysiciansW-WcorrectWanswer-(a)WemployersW
SomeWthirdWpartyWpayersWincludeWtheWinsuranceWcompany,WtheWemployer,Wmana
gedWcareWorganization,WorWtheWU.S.WgovernmentW(Medicare/Medicaid).
WhatWdefinesWethicalWpharmaceuticalWcompanies?W-WcorrectWanswer-
PharmaceuticalWcompaniesWthatWresearchWandWdevelopWnovelWdrugs.
ThanksWtoWmodernWmedicineWhowWlongWareWpeopleWnewlyWdiagnosedWwithWHIV
WexpectedWtoWlive?W-WcorrectWanswer-AnotherW50Wyears.
HowWmuchWhasWtheWaverageWAmericanWlifespanWincreasedWsinceW1890?W-
WcorrectWanswer-30Wyears
WhatWisWaWtreatmentWgroup?W-WcorrectWanswer-
AWgroupWofWpatientsWassignedWtoWreceiveWspecificWtreatment.
WhatWisWtheWmainWdifferenceWbetweenWaWblindedWandWdouble-blindedWstudy?W-
WcorrectWanswer-
InWaWdoubleWblindedWstudy,WneitherWtheWstaffWnorWtheWstudyWparticipantsWknowW
whichWsubjectsWareWinWtheWexperimentalWgroupWandWwhichWsubjectsWareWinWthe
WcontrolWgroup.
WhatWdoesWasymptomaticWmean?W-WcorrectWanswer-
WithoutWsignsWorWsymptomsWofWdisease.
WhatWisWanWapprovableWletter?W-WcorrectWanswer-
LettersWsentWbyWtheWFDAWtoWtheWapplicantWindicatingWwhetherWtheWnewWdrugWa